Atai
•
Tue, Jul 18
Tapping into AI and ML to accelerate the next generation of drug discovery
www.linkedin.com
11684
keyboard_arrow_down
Atai
•
Mon, Jun 19
Psychedelic Research: A Partnership at the Forefront
giving.massgeneral.org
0
Atai
•
Thu, Apr 27
DMX-1002: Ibogaine as a potential treatment for OUD
www.linkedin.com
0
Atai
•
Thu, Mar 23
Deuterated Etifoxine: A possible alternative to current frontline anxiety medications with a...
Atai
•
Fri, Mar 10
Anorexia is the deadliest psychiatric disorder. Could psychedelics help?
Atai
•
Mon, Mar 6
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates | ATAI Life Sciences N.V.
Atai
•
Thu, Feb 23
The Most Unexpected Sign Someone Is Having Suicidal Thoughts
Atai
•
Wed, Feb 15
How a family's struggle to help their son gave rise to controversial $400 million psychedelics...
Atai
•
Mon, Dec 19
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment...
ir.atai.life
30
Atai
•
Fri, Dec 16
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts...
ir.atai.life
7